Cargando…
Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report
Novel coronavirus disease 2019 (COVID-19) emerged in late December 2019 in Wuhan, China. Since then, COVID-19 has become a pandemic affecting more than 4.1 million people worldwide. Patients with COVID-19 have a wide spectrum of manifestations, one being cytokine release syndrome (CRS) and its fatal...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American College of Chest Physicians
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195070/ https://www.ncbi.nlm.nih.gov/pubmed/32343968 http://dx.doi.org/10.1016/j.chest.2020.04.024 |